share

Insulin, 2,7-Diaminosuberoyl, N(Alpha)(A1), N(Epsilon)(B29)- CAS NO 74504-12-4


Unit Price:

CAS No.:74504-12-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Insulin, 2,7-Diaminosuberoyl, N(Alpha)(A1), N(Epsilon)(B29)- is a chemically modified insulin derivative, specifically engineered for enhanced stability and targeted therapeutic action. This compound is critical for advanced pharmaceutical research and development, particularly in creating next-generation diabetes treatments and metabolic disorder studies. It is primarily utilized by biopharmaceutical manufacturers, academic research institutions, and contract development organizations focused on peptide-based drug discovery and formulation.

Application

  • Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel, long-acting insulin analogs and insulin receptor agonists.
  • Biomedical Research: Used in in vitro and in vivo studies to investigate insulin signaling pathways, receptor binding kinetics, and mechanisms of diabetes.
  • Drug Delivery System Development: Explored as a component in controlled-release formulations and targeted delivery platforms due to its modified structure.
  • Reference Standard: Acts as a high-purity analytical standard for quality control and method validation in peptide and biopharmaceutical analysis.
  • Metabolic Disorder Studies: Employed in preclinical research to model and test therapeutic interventions for conditions like hyperglycemia and insulin resistance.

Basic Information

Product Name Insulin, 2,7-Diaminosuberoyl, N(Alpha)(A1), N(Epsilon)(B29)-
CAS No. 74504-12-4
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms 2,7-Diaminosuberoyl Insulin; A1,B29-Suberoyl Insulin; N(Alpha)-A1,N(Epsilon)-B29-(2,7-Diaminosuberoyl)insulin; Insulin Suberoyl Derivative; Cross-linked Insulin Derivative; Diaminosuberic Acid Insulin Conjugate; B29-(2,7-Diaminosuberoyl)insulin
EINECS Contact for details

Quality Control

Our Insulin, 2,7-Diaminosuberoyl, N(Alpha)(A1), N(Epsilon)(B29)- is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for research and pharmaceutical development. Certificates of Analysis (COA) detailing all specifications are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below. This product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain stability. For long-term storage, keep desiccated.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC) Conforms
Purity (HPLC) ≥ 95.0%
Water Content (KF) ≤ 5.0%
Biological Activity Assessed per customer requirement

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.